Home > Healthcare > Healthcare IT > Telehealth > Digital Therapeutics Market

Digital Therapeutics Market Share

Report ID: GMI5408
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Digital Therapeutics Market Share

These companies focus on delivering targeted solutions for chronic disease management, mental health, and addiction recovery through innovative software platforms. Strategic partnerships, R&D investments, and collaborations with healthcare providers are common strategies among industry leaders to expand their market presence.

Digital Therapeutics Market Companies

The digital therapeutics industry is highly competitive, with prominent players including

LifeScan, Inc.
Voluntis
Omada Health Inc.
My Sugr (Roche)
Propeller Health (ResMed)
Teladoc Health
Otsuka Holdings Co., Ltd
Virta Health Corp.
DarioHealth
Pear Therapeutics, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for digital therapeutics reached an estimated USD 6.5 billion in 2022 and is anticipated to garner over USD 104 billion in revenues by 2032, given the ability of digital therapeutics (DTx) to directly deliver medical interventions to patients using clinically evaluated evidence-based devices & software to prevent, manage, and treat several diseases and disorders.

The digital therapeutics industry share from the software segment is projected to grow at 31.7% CAGR between 2023 and 2032, attributed to the capability of digital software modalities in helping patients with medication adherence while offering personalized care enabling long-term behavioral change.

The digital therapeutics market size from the diabetes segment is set to expand at 31.0% CAGR from 2023 to 2032, driven by the surging requirement and an increased cognizance of the unique benefits of digital therapeutics in precisely managing diabetes.

Prominent enterprises in the digital therapeutics industry include Otsuka Holdings Co., Ltd., LifeScan Inc., Teladoc Health, Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health, LifeScan, Inc., DarioHealth, Voluntis, My Sugr (Roche), and Virta Health Corp.